Kenichi Wakita

Title: Kenichi Wakita: Innovator in Metabolic Research

Introduction

Kenichi Wakita is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of metabolic research, holding 2 patents that showcase his innovative approach to understanding cellular processes.

Latest Patents

Wakita's latest patent is a mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products. This invention utilizes a two-hybrid system to screen for agents that can modulate a cell's ability to degrade or accumulate metabolic products. The system is designed to selectively kill a cell or express a gene in cells that have defects in their metabolic processes. One embodiment of this invention includes a mammalian cell that comprises a nucleic acid encoding a peptide binding domain and an effector gene. It also features two chimeric proteins that interact with metabolic products or ligands, allowing for the detection of changes in gene expression in response to test agents.

Career Highlights

Kenichi Wakita is affiliated with the University of California, where he continues to advance research in metabolic processes. His work has implications for understanding various diseases and developing therapeutic strategies.

Collaborations

Wakita has collaborated with notable colleagues such as Frank McCormick and Osamu Tetsu, contributing to a rich environment of innovation and research.

Conclusion

Kenichi Wakita's contributions to metabolic research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the understanding of cellular metabolism and its implications for health.